ArticleFrontiers in neurology2013

How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?

Franz Fazekas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.